Article

New York Post on 2023-01-07 00:23

Breakthrough Alzheimer's drug earns accelerated FDA approval

Leqembi has been shown in trials to slow the cognitive and functional decline of people in the early stages of Alzheimer’s disease.

Related news

WAlzheimer's drug from Biogen, partner receives FDA approval wraltechwire.com
Cambridge , Japan
BTop FDA Staffers Defend Approval of Biogen's Alzheimer's Drug 4 min read barrons.com
BA Third Expert Quits FDA Panel Over Approval of Biogen Alzheimer's Drug 2 min barrons.com
FDA seeks inquiry on Alzheimer's drug approval nwaonline.com
Brigham City
Biogen's Alzheimer's drug wins FDA approval bizjournals.com
XCOPRI Reduces Number Of Partial-Onset Seizures In Adults, Earns FDA Approval Forbes
Philadelphia
MediBeacon device earns ‘breakthrough’ designation from FDA bizjournals.com
Pfizer breast cancer drug gets accelerated FDA approval The Salt Lake Tribune
Washington
FDA grants accelerated approval to Sarepta’s Duchenne drug bizjournals.com
Omeros seeks accelerated approval from FDA for new drug bizjournals.com
Genentech pulls breast cancer drug after FDA questions accelerated approval bizjournals.com
MSanthera plummets 35% after FDA denies accelerated DMD drug approval marketwatch.com
FDA Grants Breakthrough Status to Dthera Sciences' Alzheimer's Therapeutic jdsupra.com
California , United States , Switzerland , Cranz
UT-backed anthrax treatment earns FDA approval bizjournals.com
Another controversial FDA approval for a new Alzheimer's medication newatlas.com
Europe
MLilly gets FDA approval for Alzheimer's diagnostic agent marketwatch.com
Europe , Canada
FDA approval of Biogen's Alzheimer's drug leaves some 'disappointed'Fox News
FDA adviser resigns over approval of new Alzheimer's drug CNN
Mayo Clinic